Forewarned is forearmed: Arm with HIF activation

Nephrology Dialysis Transplantation

Volumn 25, Issue 5, 2010, Pages 1385-1387

  Nangaku, Masaomi ^a   Tanaka, Tetsuhiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IMMUNOSUPPRESSIVE AGENT; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN LYSINE 6 OXIDASE; REAGENT; RETINOIC ACID RECEPTOR; VON HIPPEL LINDAU PROTEIN;

ADIPOCYTE; ANGIOGENESIS; CELL FUNCTION; DISEASE PREDISPOSITION; ENDOTHELIUM; ENZYME DEGRADATION; FOLLOW UP; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENE TARGETING; GENETIC CODE; GRAFT REJECTION; GRAFT SURVIVAL; HEMODIALYSIS; HYDROXYLATION; INCIDENCE; ISCHEMIA; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY TRANSPLANTATION; NONHUMAN; ORGAN DONOR; PERITONEAL DIALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; REPERFUSION; REPERFUSION INJURY; SHORT SURVEY; UPREGULATION;

ANIMALS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; ISCHEMIC PRECONDITIONING; KIDNEY TRANSPLANTATION;

EID: 77951682766     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq117     Document Type: Short Survey

References (18)

1. Nangaku M, Eckardt KU. Hypoxia and the HIF system in kidney disease. J Mol Med 2007; 85: 1325-1330 (Pubitemid 50004091)
2. Bernhardt WM, Gottmann U, Doyon F, et al. Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model. Proc Natl Acad Sci USA 2009; 106: 21276-21281
3. Bonventre JV. Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 2002; 11: 43-48
4. Matsumoto M, Makino Y, Tanaka T, et al. Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol 2003; 14: 1825-1832 (Pubitemid 36750477)
5. Ma D, Lim T, Xu J, et al. Xenon preconditioning protects against renal ischemic-reperfusion injury via HIF-1alpha activation. J Am Soc Nephrol 2009; 20: 713-720
6. Bernhardt WM, Câmpean V, Kany S, et al. Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure. J Am Soc Nephrol 2006; 17: 1970-1978 (Pubitemid 44036181)
7. Faleo G, Neto JS, Kohmoto J, et al. Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor. Transplantation 2008; 85: 1833-1840
8. Bagul A, Hosgood SA, Kaushik M, Nicholson ML. Carbon monoxide protects against ischemia-reperfusion injury in an experimental model of controlled nonheartbeating donor kidney. Transplantation 2008; 85: 576-581
9. Nizet V, Johnson RS. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 2009; 9: 609-617
10. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009; 53: 961-973
11. Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001; 281: F887-F899 (Pubitemid 33123835)
12. Kaur J, Adya R, Tan BK, Chen J, Randeva HS. Identification of che-merin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem Biophys Res Commun 2010; 391: 1762-1768
13. Alcudia JF, Martinez-Gonzalez J, Guadall A, Gonzalez-Diez M, Badimon L, Rodriguez C. Lysyl oxidase and endothelial dysfunction: mechanisms of lysyl oxidase down-regulation by pro-inflammatory cytokines. Front Biosci 2008; 13: 2721-2727 (Pubitemid 351599714)
14. Takeda K, Cowan A, Fong GH. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation 2007; 116: 774-781 (Pubitemid 47255995)
15. Aragonés J, Schneider M, Van Geyte K, et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 2008; 40: 170-180 (Pubitemid 351171394)
16. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17: 17-25 (Pubitemid 39274273)
17. Kondo K, Klco J, Nakamura E, Lechpammer M, Kaelin WG Jr. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 2002; 1: 237-246 (Pubitemid 41039148)
18. Tanaka T, Nangaku M. Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKD. J Pharmacol Sci 2009; 109: 24-31